Category Patents/Designs/Trade Secrets

Concern Erupts Over WTO System And Medicines Shipments; TRIPS Talks Rekindling

By William New The ambassadors to the World Trade Organization from Brazil and India on Tuesday charged that other WTO members had no grounds to block legitimate shipping of generic medicines on the basis of potential intellectual property rights conflicts…

IP Owners Face Tough Legal Issues In United States In 2009

By Steven Seidenberg for Intellectual Property Watch
2009 could be a bad year for IP owners in the United States.

For patent owners, it may be particularly tough. The US courts are likely to continue their recent trend of cutting back on patent rights, according to many experts. The question is: what rights may be cut back and by how much?

Copyright and trademark owners in the United States face a different set of troubles. They are struggling to protect their rights in the digital world, and it is far from certain how they will fare.

Potential Names For Obama IP Team Swirl; WTO IP Chief “Imminent”

By Liza Porteus Viana for Intellectual Property Watch and William New
Changes in several key international agencies and governments will bring a cadre of new faces to positions that address intellectual property policy, and some potential names for those spots have been circulating in recent weeks.

The naming of the new chief of the World Trade Organization IP Division is "imminent," according to sources close to the process. And as US President Barack Obama began his first weeks in office in late January, many IP-related positions also remain unfilled.

New International Pharma Industry Leader Brings Prospect Of Change

By William New
Alicia Greenidge represents a change for the global pharmaceutical and biotechnology industry, but as she grows into her role as the head of the industry's international trade association, it is unclear whether there will be substantive changes on policy relating to intellectual property and public health. Key policy areas include counterfeit medicines and funding for research and development into diseases afflicting poor populations in ways that echo past industry approaches, but Greenidge brings a new focus on networking and negotiation.